FDA Approval of Senseonics Eversense® CGM for Use for Up to 6 Months
FDA approves Senseonics Eversense® E3, the first long-term implantable CGM system, and the E3 includes technology that extends the use for up to 6 months.
100 Years, 100 Breakthrough T1D Scientists: The BB Rat—An Animal Model of Type 1 Diabetes
In 1974, a colony of non-diabetic BB rats develops diabetes. Examination of their pancreases revealed that they had no beta cells.
The First Gene-Edited Cell Replacement Therapy Takes a Step Forward
The first person has received ViaCyte and CRISPR's cell replacement therapy.
FDA Authorizes a Fourth Artificial Pancreas System
The FDA authorized the Insulet Omnipod 5, the world’s first tubeless, wearable system for people 6 and older, using an algorithm that began by Breakthrough T1D funding.
Interview with our New Community Screening and Clinical Trial Education Director
Breakthrough T1D has a new community screening and clinical trials education director. She's been a volunteer and now staff since her daughter was diagnosed in 2002.
New Study Shows Kids 1+ Benefit from Artificial Pancreas Technology
A new paper published in the New England Journal of Medicine shows hybrid closed loop systems help children as young as 1 year old achieve better glycemic control.
100 Years, 100 Breakthrough T1D Scientists: Gian Franco Bottazzo, M.D.
In honor of the 100th anniversary of insulin, we are launching “100 Years, 100 Breakthrough T1D Scientists.” The first up: Gian Franco Bottazzo, M.D.
CDC Study: Children Who Have Recovered from COVID-19 May Be at Increased Risk of Diabetes
CDC researchers report an apparent association between pediatric COVID-19 and diabetes diagnoses.
Celebrating the Best of 2021
In 2021, Breakthrough T1D has seen tremendous progress in accelerating cures, improving lives, and advocating for people with type 1 diabetes and their loved ones.
Targeting a New Hormone Helps to Prevent Type 1 Diabetes
A publication authored by Harvard University scientists has found that targeting a new hormone, FABP4, can enhance beta cell function and prevent T1D.
